Strait Hormuz Back Under Full Conflict, Markets React
The strait hormuz back under renewed conflict tests oil bulls and hedges. Markets brace for higher volatility as crud...
A concise guide to spotting tax-friendly dividend ETFs, including key metrics and quick tips to boost after-tax performance.
22,830 articlesThe strait hormuz back under renewed conflict tests oil bulls and hedges. Markets brace for higher volatility as crud...
As Netflix stumbles, investors wonder if Disney down 2026 offers a rare contrarian opportunity. This article digs int...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
Amazon's latest move highlights a broader theme: AI investment can lift near-term costs even as revenue opportunities...
Ackman's bold pivot away from Alphabet toward AI bets has investors talking. This guide breaks down what happened, wh...
Bitcoin and the broader crypto complex could swing this week as inflation data, energy tensions, and market signals i...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Cybersecurity stocks are commanding attention as threats rise and tech spending grows. This July guide breaks down ho...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...